ライフサイエンスコーパス: immunoglobulin heavy chain gene

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 onal machinery to the variable region of the immunoglobulin heavy chain gene.

2 shown to be important for expression of the immunoglobulin heavy chain gene.

3 M variable genes are most similar to that of immunoglobulin heavy chain genes.

4 ing microdissection and PCR amplification of immunoglobulin heavy chain genes.

5 nucleotides within the CDRIII region of the immunoglobulin heavy chain gene and displayed as Fd coat

6 region-binding transcriptional regulator of immunoglobulin heavy chain genes and of E2F1-dependent c

7 ve variant of CLL characterized by unmutated immunoglobulin heavy-chain genes and with a single nucle

8 mentarity-determining region 3 (CDR3) of the immunoglobulin heavy-chain gene as a clonal marker to st

9 efect in the VH to DJH rearrangement step of immunoglobulin heavy chain gene assembly even though the

10 gle inoculation of plasmid DNA containing an immunoglobulin heavy-chain gene coding in the complement

11 ed as at least 1 of the following: unmutated immunoglobulin heavy chain genes, deletion 17p or 11q, o

12 merase to the HIV-1 LTR, the B cell-specific immunoglobulin heavy chain gene enhancer (IgHE) was inse

13 interaction of these factors with the human immunoglobulin heavy chain gene enhancer regions in t(14

14 core unwinding element in the 3' MAR of the immunoglobulin heavy chain gene enhancer revealed the se

15 In a cell-free system based on the immunoglobulin heavy chain gene enhancer, we show that T

16 required for the complete activation by the immunoglobulin heavy chain gene enhancer.

17 activation of c-myc promoter activity by the immunoglobulin heavy chain gene enhancer.

18 n a loss of promoter activity induced by the immunoglobulin heavy chain gene enhancer.

19 within the bcl-2 5' flanking region and the immunoglobulin heavy chain gene enhancers.

20 within the bcl-2 5' flanking region and the immunoglobulin heavy-chain gene enhancers.

21 ity determining region III of the rearranged immunoglobulin heavy chain gene has been the target for

22 Immunoglobulin heavy chain genes have composite exons; r

23 2: 18 of 29 (62%) had a translocation of the immunoglobulin heavy chain gene IGH@ on 14q32 to CRLF2 i

24 Chromosomal rearrangements involving the immunoglobulin heavy chain gene (IGH) at 14q32 are obser

25 The immunoglobulin heavy chain gene (IgH) complementarity de

26 that establishes the structure of the 2.8-Mb immunoglobulin heavy chain gene (IgH) locus in pro-B cel

27 entarity determining region (CDR III) of the immunoglobulin heavy chain gene (IgH) provides a useful

28 B cell development and rearrangement of the immunoglobulin heavy chain gene (Igh).

29 Sequence analysis of the immunoglobulin heavy chain genes (IgH) has demonstrated

30 nd the mechanisms underlying the role of the immunoglobulin heavy-chain gene (IgH) 3' enhancers on bc

31 visualization of V(D)J recombination of the immunoglobulin heavy-chain gene (Igh) in living pro-B ce

32 neration sequencing approach to characterize immunoglobulin heavy-chain gene (IGH) repertoires in pat

33 14;18) lymphomas, bcl-2 is juxtaposed to the immunoglobulin heavy-chain gene (IgH), resulting in incr

34 rimers to amplify the CDR3 VDJ region of the immunoglobulin heavy chain gene in combination with an i

35 and relevant secondary surrogate markers of immunoglobulin heavy-chain gene, including methylation o

36 factor PU.1 is an important regulator of the immunoglobulin heavy chain gene intronic enhancer, or mu

37 Regulation of the immunoglobulin heavy chain gene is controlled in part by

38 Translocation of the bcl-2 gene to the immunoglobulin heavy chain gene is the most common alter

39 gene driven by the powerful enhancer of the immunoglobulin heavy chain gene, leading to uncontrolled

40 It positively induces gene rearrangements at immunoglobulin heavy chain gene loci by transcriptionall

41 tic factors such as interphase cytogenetics, immunoglobulin heavy-chain gene mutational analysis, and

42 rs (interphase cytogenetics) but not others (immunoglobulin heavy-chain gene mutational status, zeta-

43 l-1 proto-oncogene from chromosome 11 to the immunoglobulin heavy chain gene on chromosome 14, result

44 Successful in-frame rearrangement of immunoglobulin heavy chain genes or T cell antigen recep

45 HS) 1, 2, 3, and 4) located 3' of the murine immunoglobulin heavy chain gene play a role in activatin

46 vel function of the alpha chain in promoting immunoglobulin heavy chain gene rearrangement leading to

47 ndergo clonal expansion following successful immunoglobulin heavy chain gene rearrangement.

48 t role in the lineage-specific regulation of immunoglobulin heavy chain gene rearrangement.

49 D45, CD19, CD5, CD10, kappa, and lambda) and immunoglobulin heavy-chain gene rearrangement by reverse

50 angement occurred in the absence of complete immunoglobulin heavy-chain gene rearrangement.

51 Recent work studying immunoglobulin-heavy chain gene rearrangement postulates

52 ction amplification and sequencing of clonal immunoglobulin heavy chain gene rearrangements and oncog

53 was used to confirm amplification of clonal immunoglobulin heavy chain gene rearrangements and to es

54 Clonal immunoglobulin heavy chain gene rearrangements were demo

55 s of B-cell differentiation antigens, clonal immunoglobulin heavy chain gene rearrangements, and expr

56 ion on a polymerase chain reaction (PCR) for immunoglobulin heavy-chain gene rearrangements in the fi

57 Southern blot hybridization showed immunoglobulin heavy-chain gene rearrangements in the tu

58 rk that regulates B cell fate commitment and immunoglobulin heavy-chain gene recombination.

59 on initiation factor-I (TFII-I), to activate immunoglobulin heavy chain gene transcription in the nuc

60 s accomplished using plasmid DNA encoding an immunoglobulin heavy-chain gene under the control of imm

61 0 years, and in prognostic groups defined by immunoglobulin heavy chain gene (V(H)) mutation status a

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。